+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Emesis - Pipeline Insight, 2024 - Product Thumbnail Image

Emesis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Norovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Norovirus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Elafibranor Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Elafibranor Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Dyspepsia - Pipeline Insight, 2024 - Product Thumbnail Image

Dyspepsia - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
Short Bowel Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Short Bowel Syndrome - Epidemiology Forecast - 2034

  • Report
  • January 2024
  • 66 Pages
  • Global
From
From
From
Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Vasopressin Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vasopressin Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Lipoxygenase Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Lipoxygenase Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Serotonin 3 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin 3 receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more